What are the common side effects of Rizatriptan (Maxalt) and how can they be managed in a patient taking the medication for migraine attacks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Side Effects of Rizatriptan and Their Management

The most common side effects of rizatriptan are dizziness, asthenia/fatigue, somnolence, and nausea, which are typically mild, transient (lasting 2-3 hours), and dose-related. 1

Primary Side Effects by Category

Cardiovascular and Pressure Sensations

  • Chest pain/tightness/pressure and heaviness occurs in approximately 3% of patients taking the 10 mg dose 2
  • Neck/throat/jaw pain, tightness, or pressure affects about 2% of patients 2
  • Tachycardia and bradycardia are documented cardiac rhythm disturbances, though specific incidence rates vary 2
  • These pressure sensations do not indicate actual cardiac ischemia in most cases but warrant evaluation if severe or persistent 1

Neurological Effects

  • Dizziness occurs in 9% of patients on the 10 mg dose versus 5% on placebo 1
  • Somnolence affects 8% of patients on 10 mg versus 4% on placebo 1
  • Paresthesias (abnormal sensations) occur in 4% of patients on 10 mg 1
  • Headache paradoxically occurs in 2% of patients 1

General Systemic Effects

  • Asthenia/fatigue affects 7% of patients on 10 mg versus 2% on placebo 1
  • Warm sensations are frequently reported 1

Gastrointestinal Effects

  • Nausea occurs in 6% of patients on 10 mg versus 4% on placebo 1
  • Dry mouth affects 3% of patients 1
  • Diarrhea and vomiting are less common but documented 1

Management Strategies

For Sensory Disturbances

  • If unpleasant sensory disturbances occur with rizatriptan, switching to a different triptan may be beneficial as individual response varies significantly 3
  • Patients should trial the medication for 2-3 headache episodes before abandoning therapy, as response can vary between attacks 3

For Cardiovascular Symptoms

  • Reassure patients that chest pressure/heaviness is common and usually benign, but screen for true cardiac contraindications before prescribing 1
  • Rizatriptan is absolutely contraindicated in patients with coronary artery disease, ischemic vascular conditions, vasospastic coronary disease, or uncontrolled hypertension 2, 4
  • Consider alternative agents such as gepants (ubrogepant, rimegepant) for patients with cardiovascular contraindications 4

For Neurological Side Effects

  • Advise patients to avoid driving or operating machinery if experiencing significant dizziness or somnolence 1
  • These effects are typically transient, lasting 2-3 hours 5

Dose-Related Considerations

  • Side effects are dose-related; the 5 mg dose has lower incidence of adverse effects than the 10 mg dose 1
  • Consider starting with 5 mg in patients concerned about tolerability, though efficacy is reduced 1
  • Patients taking propranolol should use the 5 mg dose due to drug interactions 2

Critical Safety Warnings

Medication Overuse Headache Prevention

  • Limit rizatriptan use to no more than 2 days per week and treat no more than 4 headaches per 30-day period to prevent medication-overuse headache 4
  • If patients require acute treatment more than twice weekly, initiate preventive therapy immediately 4

Drug Interactions

  • Do not combine with ergot-type medications, MAOIs, other triptans, or SSRIs due to risk of serotonin syndrome and vasospastic reactions 2
  • Avoid use within 24 hours of another triptan or ergotamine 2
  • Reduce dose to 5 mg when used with propranolol or cimetidine 2

Comparative Tolerability

  • Rizatriptan has a higher incidence of adverse events (39%) compared to naratriptan (29%) but similar rates to other triptans 6
  • Despite higher side effect rates, rizatriptan provides superior efficacy with faster onset and higher pain-free rates than naratriptan or zolmitriptan 7, 6

When to Discontinue or Switch Therapy

  • If side effects are intolerable after 2-3 trials, switch to a different triptan formulation 3
  • If partial response with tolerable side effects, consider combining with an NSAID rather than switching 8
  • Serious cardiovascular symptoms (severe chest pain, arrhythmias) require immediate discontinuation and cardiac evaluation 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Triptans and Sensory Disturbances

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rizatriptan Dosing Considerations for Migraine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Rizatriptan in the treatment of migraine.

Clinical therapeutics, 1999

Guideline

Triptan Dosing for Pediatric Patients with Vestibular Migraine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.